Literature DB >> 6427218

Endo-beta-D-galactosidases of Bacteroides fragilis and Escherichia freundii hydrolyze linear but not branched oligosaccharide domains of glycolipids of the neolacto series.

P Scudder, P Hanfland, K Uemura, T Feizi.   

Abstract

The specificities of the endo-beta-galactosidases of Bacteroides fragilis and Escherichia freundii towards linear and branched oligosaccharides of the lacto-N-glycosyl series were investigated using as substrates glycolipids containing (a) linear neolactotetra - or hexaosyl sequences, (b) branched biantennary neolactooctaosyl sequences, and (c) triantennary neolactononaor dodecaglycosyl sequences. Glycolipid and oligosaccharide hydrolysis products were identified by tlc and/or paper chromatography. The rate of hydrolysis was assessed in time course experiments in which the oligosaccharides released were quantified as 3H-labeled alditols. The salient observations were as follows. (i) With the substrates thus far tested in the present and a previous study ( Scudder , P., Uemura , K., Dolby , J., Fukuda, M.N., and Feizi , T. (1983) Biochem. J. 213, 485-494), the endo-beta-galactosidases from B. fragilis and E. freudii have indistinguishable specificities. (ii) The beta-galactosidic linkage of the branch point sequence (Formula: see text) is completely resistant to hydrolysis by these enzymes, although the unbranched sequence GlcNAc beta 1-3Gal beta 1-4GlcNAc/Glc is readily cleaved. (iii) At an optimal concentration of detergent, the endo-beta-galactosidase susceptibility of the GlcNAc beta 1-3Gal beta 1-4Glc sequence near the ceramide moiety of branched glycolipids is similar to that of the corresponding sequence in linear glycolipids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells.

Authors:  J Mendicino; S Sangadala
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  N-linked oligosaccharides during human renal organogenesis.

Authors:  S Fleming
Journal:  J Anat       Date:  1990-06       Impact factor: 2.610

Review 3.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

4.  Characterisation of tissue-specific oligosaccharides from rat brain and kidney membrane preparations enriched in Na+,K+-ATPase.

Authors:  R A Clark; B Küster; M Benallal; B M Anner; R A Dwek; D J Harvey; D R Wing
Journal:  Glycoconj J       Date:  1999-08       Impact factor: 2.916

5.  Characterization of a Borna disease virus glycoprotein, gp18.

Authors:  S Kliche; T Briese; A H Henschen; L Stitz; W I Lipkin
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Localization of blood-group-related linear poly-N-acetyllactosamine structure in different human tissues by Griffonia simplicifolia agglutinin-II staining following endo-beta-galactosidase digestion.

Authors:  N Ito; S Kawahara; Y Hirano; Y Morimura; K Nakajima; K Uchida; T Hirota
Journal:  Histochem J       Date:  1994-04

7.  Single mid-chain GlcNAc beta 1-6Gal beta 1-4R sequences of linear oligosaccharides are resistant to endo-beta-galactosidase of Bacteroides fragilis.

Authors:  O Renkonen; L Penttilä; R Niemelä; A Leppänen
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

8.  Developmentally-related changes in surface membrane glycopeptides of murine haemopoietic cells.

Authors:  J T Gallagher; A J Morris; T M Dexter
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

9.  Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.

Authors:  Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

10.  Characterization of I/F1 glycoprotein as a receptor for Mycoplasma pneumoniae.

Authors:  U R Hengge; M Kirschfink; A L König; W Nicklas; D Roelcke
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.